The entry of digital technologies in the healthcare sector creates enormous financial potential for the biopharma industry. However, it also creates major challenges: A study titled “Driving the future of health” conducted by Strategy&, the strategic consulting firm of PwC, among 120 international senior executives of the biggest biopharma companies forecasts an increase of the global healthcare market volume by 10%, from US$ 10.6 trillion in 2018 to US$ 11.6 trillion by 2030.
Read full article